NCT03956628 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

MacIntyre D, Carr A
Evaluation of the effectiveness of the stay safe primary prevention programme for child sexual abuse. Child Abuse Negl. 1999 Dec;23(12):1307-25.
MacIntyre D, Carr A
Helping children to the other side of silence: a study of the impact of the stay safe programme on Irish children's disclosures of sexual victimization. Child Abuse Negl. 1999 Dec;23(12):1327-40.

Evaluation of Preventive (Stay Safe) Training Program of Child Abuse for Teachers and Children: A Randomized Controlled Trial From Multan City

Clinical trial NCT03956628 - References